Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors

Published:2010-11-16 Issue:2 Volume:68 Page:505-511
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Tanioka M.,Nokihara H.,Yamamoto N.,Yamada Y.,Yamada K.,Goto Y.,Fujimoto T.,Sekiguchi R.,Uenaka K.,Callies S.,Tamura T.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-010-1506-7.pdf

Reference22 articles.

1. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921. doi: 10.1038/nm0897-917

2. Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3:46–54. doi: 10.1038/nrc968

3. Shen YC, Hu FC, Jeng YM, Chang YT, Lin ZZ, Chang MC, Hsu C, Cheng AL (2009) Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survival. Cancer Epidemiol Biomarkers Prev 18(2):417–423. doi: 10.1158/1055-9965.EPI-08-0691

4. Carter BZ, Wang RY, Schober WD, Milella M, Chism D, Andreeff M (2003) Targeting survivin expression induces cell proliferation defect and subsequent cell death involving mitochondrial pathway in myeloid leukemic cells. Cell Cycle 2:488–493

5. Ansell SM, Arendt BK, Grote DM, Jelinek DF, Novak AJ, Wellik LE, Remstein ED, Bennett CF, Fielding A (2004) Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin’s lymphoma. Leukemia 18:616–623. doi: 10.1038/sj.leu.2403281

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular Vesicle (EV) Survivin for Cancer Diagnostics and Therapeutics: A Review;Frontiers in Bioscience-Landmark;2024-08-22

2. Revealing cancer driver genes through integrative transcriptomic and epigenomic analyses with Moonlight;2024-03-15

3. Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target;Journal of Drug Targeting;2024-02

4. Inhibition of survivin by 2′-O-methyl phosphorothioate-modified steric-blocking antisense oligonucleotides;RSC Advances;2024

5. Targeting survivin for cancer therapy: Strategies, small molecule inhibitors and vaccine based therapeutics in development;Life Sciences;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3